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Supplementary Table 1 │ Participants of the European Conference on Risk-Stratified Prevention and 
Early Detection of Breast Cancer, Hall in Tirol, Austria, 26––28 June 2019  
Delegate Affiliation 
Prof. Angel Carracedo Alvarez Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago 
de Compostela, Santiago de Compostela, A Coruña, Spain. 
Dr Nadine Andrieu Institut Curie, Paris, France. 
Prof. Antonis C. Antoniou Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University 
of Cambridge, UK. 
Dr Corinne Balleyguier  Department Medical Imaging, Institut Gustave Roussy, Villejuif, France. 
Dr James Barrett Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Camille Baron  Unicancer, Paris, France. 
Dr Julie Bennett Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Proteeti Bhattacharjee Department of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek 
Hospital, Amsterdam, The Netherlands. 
Prof. Stig Bojesen Department of Clinical Medicine, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, 
Denmark.  
Dr Ineke Bolt  Department of Medical Ethics and Philosophy of Medicine, Erasmus MC, Rotterdam, The 
Netherlands. 
Prof. Mireille Broeders Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands. 
Mr Jeroen van de Broek Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 
Dr Jean Benoit Burrion  Cancer Prevention and Screening, Medical general management, Quality unit, Institut Jules Bordet, 
Brussels, Belgium. 
Dr Xavier Castells  Laboratory of Translational Medicine and Decision Sciences (TransLab), Department of Medical 
Sciences, Medicine Faculty, Universitat de Girona, Girona, Spain. 
Dr Carlos Tarin Cerezo Department of Basic Medical Sciences, Universidad CEU San Pablo, Campus de Moncloa Calle 
Julián Romea, Madrid, Spain.  
Prof. Jenny Chang-Claude Genetic Epidemiology Unit, Division of Cancer Epidemiology, German Cancer Research Center 
(DKFZ) Heidelberg, Medical Faculty, University of Heidelberg, Germany. 
Prof. Georgia Chenevix-Trench  Cancer Genetics Laboratory, Department of Genetics and Computational Biology, Queensland 
Institute of Medical Research (QIMR) Berghofer, Brisbane, Australia. 
Prof. Anna Maria Chiarelli Dalla Lana School of Public Health, University of Toronto, Cancer Care Ontario, Toronto, Ontario, 
Canada. 
Dr Hans Concin  AKS Vorarlberg, Austria.  
Prof. Jack Cuzick  Wolfson Institute of Preventive Medicine, Barts and The London, Centre for Cancer Prevention, 
Queen Mary University of London, UK. 
Dr Kamila Czene Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 
Dr Suzette Delaloge  Breast Cancer Department, Gustave Roussy Institute, Paris, France. 
Prof. Peter Devilee Department of Human Genetics, Department of Pathology, Leiden University Medical Centre, 
Leiden, The Netherlands. 
Dr Julia Dick Center of Family Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany. 
Dr Alison Dunning Centre for Cancer Genetic Epidemiology, University of Cambridge, UK.  
Pro.f Douglas F. Easton Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University 
of Cambridge, UK. 
Prof. Laurence Eloy  Centre de recherche du CHU de Québec - Université Laval, CHUL, Québec, Canada. 
Dr Christoph Engel Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, 
Germany. 
Prof. Laura Esserman Carol Franc Buck Breast Care Center, University of California, San Francisco, San Francisco, CA, 
USA. 
Prof. Gareth Evans  Division of Evolution & Genomic Sciences, University of Manchester, UK. 
Dr Iona Evans  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Mikael Eriksson Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 
Dr Angelique Flöter-Rådestad Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. 
Prof. David French  Division of Psychology & Mental Health, School of Social Sciences, University of Manchester, UK. 
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Prof. Fiona Gilbert  Centre for Mathematical Imaging in Healthcare, University of Cambridge, UK.  
Prof. Carla van Gils Department of Epidemiology, UMC Utrecht, Division Julius Centrum, Utrecht, The Netherlands. 
Dr Livia Giordano  CPO Piemonte Referral Center for Epidemiology and Oncology Prevention in Piemonte, SSD 
Epidemiology Screening - CRPT, Torino, Italy.  
Dr Artemisa Gogollari  Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer 
Medicine, Innsbruck, Austria. 
Dr Ewan Gray Faculty of Biology, Medicine and Health, Manchester Centre for Health Economics (MCHE), 
University of Manchester, UK.  
Dr Michal Guindy  Assuta Medical Centers, Israel.  
Dr Ivo Gut Centro Nacional de Análisis Genómico, Centre for Genomic Regulation (CNAG-CRG), Barcelona, 
Spain. 
Dr Kevin ten Haaf  Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 
Prof. Per Hall Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 
Department of Oncology, Södersjukhuset, Stockholm, Sweden. 
Dr Lára Hallsson  Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer 
Medicine, Innsbruck, Austria. 
Dr Shaun Haran  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Sirpa Heinävaara  Finnish Cancer Registry, Helsinki, Finland. 
Ms Valerie Helin Predilife, Villejuif, France. 
Dr Zdenko Herceg  Epigenetic Group, The International Agency for Research on Cancer (IARC), WHO, Lyon, France. 
Dr Weang-Kee Ho  School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham 
Malaysia, Selangor, Malaysia. 
Dr Miguel de la Hoya Molecular Oncology Laboratory CIBERONC, Hospital Clínico San Carlos, IdISSC (Instituto de 
Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain. 
Prof. John Hopper Centre for Epidemiology and Biostatistics Research, Breast Cancer Unit, The University of 
Melbourne, Australia.  
Dr Tom Hueting Evidencio, Haaksbergen, The Netherlands. 
Prof. Teo Soo Hwang Cancer Research Malaysia, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia. 
Dr Urška Ivanuš Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia. 
Dr Beate Jahn  Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Dr Katja Jarm Epidemiology and Cancer Registry, DORA Registry and Call Center, Institute of Oncology, Ljubljana, 
Slovenia. 
Ms Allison Jones  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Susanne Knapp  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Ms Mona Knotek-Roggenbauer Europa Donna - The European Breast Cancer Coalition, Austria.  
Prof. Harry de Koning Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 
Dr Mateja Krajc Ern Genturis, Institute of Oncology, Ljubljana, Slovenia. 
Dr Ayse G. Kurt  Department of Obstetrics and Gynecology, Clinic of the Ludwig-Maximilians-University Munich, 
Germany.  
Dr Anders Kvist BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation, Lund 
University, Lund, Sweden. 
Dr Olivia Leavy  Department of Health Sciences, Genetic Epidemiology Group Research, University of Leicester, 
Leicester, UK. 
Dr Andreas Leimbach  Eurofins Genomics Europe Sequencing GmbH, Konstanz, Germany.  
Dr Fabienne Lesueur Institut Curie, Paris, France. 
Dr Shuai Li Centre for Epidemiology and Biostatistics Research, Breast Cancer Unit, The University of 
Melbourne, Australia. 
Dr Jan-Willem van de Loo European Commission, DG Research & Innovation, Unit E2 – Combatting diseases, CDMA 00/170, 
1049 Brussels, Belgium. 
Dr Sonia Mardinian Unicancer, Paris, France. 
Prof. Hanne Meijers-Heijboer Department Of Clinical Genetics, Vu University Medical Center – VUMC, Amsterdam, The 
Netherlands. 
Prof. Andres Metspalu EGCUT - The Estonian Genome Center, University of Tartu, Estonia. 
Dr Sandrine de Montgolfier  IRIS Institute for Interdisciplinary Research on Social Issues, Paris, France. 
Dr Sowmiya Moorthie PHG Foundation, Cambridge, UK. 
Dr Anna Gonzalez Neira Human Genotyping Core Unit, National Center for Oncology Research (CNIO), Madrid, Spain.  
Dr Nuno Nene Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Carolyn Nickson Melbourne School of Population and Global Health, The University of Melbourne, Australia.  
Prof. Håkan Olsson BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation, Lund 
University, Lund, Sweden. 
Dr Wilhelm Oberaigner Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Dr Tobias Paprotka  Eurofins Genomics Europe Sequencing GmbH, Konstanz, Germany. 
Prof. Nora Pashayan  Department of Applied Health Research, Institute of Epidemiology and Healthcare, University 
College London, UK. 
Prof. Paul Pharoah Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University 
of Cambridge, UK. 
Dr Margarita Posso Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), 
Barcelona, Spain. 
Dr Nicolien van Ravesteyn Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 
Prof. Gad Rennert Carmel Medical Center, Technion, Clalit, Haifa, Israel. 
Dr Beatriz Sobrino Rey  Universidade de Santiago de Compostela, Santiago de Compostela, Spain. 
Mr David Ritchie Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. 
Dr Daniel Roche SOPHiA Genetics, Bidart, France. 
Dr Marta Roman Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), 
Barcelona, Spain. 
Dr Atocha Romero  Department of Medical Oncology, Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain. 
Dr Matti Rookus  Division Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van 
Leeuwenhoek Hospital, Amsterdam, The Netherlands. 
Dr Paolo Giorgi Rossi  Epidemiology Service, Azienda USL of Reggio Emilia, IRCCS, Reggio Emilia, Italy. 
Dr Tytti Sarkeala Finnish Cancer Registry, Helsinki, Finland. 
Dr Marjanka Schmidt Department of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek 
Hospital, Amsterdam, The Netherlands. 
Prof. Rita Schmutzler Center of Family Breast and Ovarian Cancer, University Hospital Cologne, Cologne, Germany. 
Prof. Nereo Segnan Department of Cancer Screening and Unit of Cancer Epidemiology, Center for Epidemiology and 
Prevention in Oncology, CPO Piedmonte, WHO Collaborative Center for Cancer Early Diagnosis 
and Screening, Torino, Italy. 
Prof. Uwe Siebert  Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer 
Medicine, Innsbruck, Austria. 
Prof. Sabine Siesling Netherlands Comprehensive Cancer Organisation (IKNL), Department Research and Development, 
Utrecht, The Netherlands. 
University of Twente, Technical Medical Centre, 
Department Health Technology and Services Research, Enschede, The Netherlands. 
Prof. Jacques Simard CHU de Québec - Université Laval Research Center, Genomics Center, Québec, Canada. 
Dr Efrat Slonim  Assuta Medical Centers, Israel. 
Prof. Melissa Southey Genetic Epidemiology Laboratory (GEL), Department of Pathology, The University of Melbourne, 
Australia. 
Dr Gaby Sroczynski  Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department 
of Public Health, Health Services Research and HTA, UMIT-University for Health Sciences, Medical 
Informatics and Technology, Hall in Tirol, Austria. 
Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer 
Medicine, Innsbruck, Austria. 
Prof. Ewout Steyerberg Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. 
Prof. Dominique Stoppa-Lyonnet Institut Curie, Paris, France. 
Dr Karin Sundström  Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. 
Dr Francois Taban Clinique Générale-Beaulieu, Geneva, Switzerland.  
Dr Marc Tischkowitz Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical 
Research Centre, University of Cambridge, Cambridge, UK. 
Dr Krista Tromp  Department of Medical Ethics and Philosophy of Medicine, Erasmus MC, Rotterdam, The 
Netherlands. 
Prof. Clare Turnbull Division of Genetics and Epidemiology, Institute Of Cancer Research, London, UK. 
Dr Lucie Veron Institut Gustave Roussy, Villejuif, France. 
Dr Benjamin Verret Institut Gustave Roussy, Villejuif, France. 
Dr Cecile Vissac-Sabatier French Breast Cancer Intergroup, Unicancer, Paris, France. 
Dr Odette Wegwarth  Max Planck Institute for Human Development, Center for Adaptive Rationality, Harding Center for 
Risk Literacy, Berlin, Germany. 
Prof. Jelle Wesseling Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 
Amsterdam, The Netherlands. 
Prof. Martin Widschwendter  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Mrs Jiran Vatankhah Atashgah  Department of Women's Cancer, Institute for Women's Health, University College London, London, 
UK. 
Dr Maaike Vreeswijk Leiden University Medical Center, Leiden, The Netherlands. 
Dr Maryam Yahiaoui-Doktor  Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany. 
 
